arrow
B

Bingnan Wang

fudan university shanghai cancer center
H指数:18
被引数:1,140

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration

新辅助辛替利单抗、白蛋白结合型紫杉醇和卡铂治疗局部晚期可切除食管鳞状细胞癌: 临床研究和机制探索

2026-01-170
OAAI
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations (vol 619, 217668, 2025)

FGFR1/2的选择性降解克服了具有FGFR1/2改变的ER+乳腺癌的抗雌激素耐药性(卷619,217668,2025)

2025-06-020
OA